US Stock MarketDetailed Quotes

KURA Kura Oncology

Watchlist
  • 7.840
  • -0.010-0.13%
Close Mar 21 16:00 ET
  • 7.820
  • -0.020-0.26%
Post 20:01 ET
633.12MMarket Cap-3.88P/E (TTM)

Kura Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
207.61%134.32M
884.46%269.13M
-49.65%-43.44M
-66.02%-42.53M
-36.16%-48.84M
-13.41%-124.82M
-29.32%-34.31M
-38.16%-29.03M
15.57%-25.62M
-11.47%-35.87M
Net income from continuing operations
-13.99%-173.98M
55.09%-19.22M
-40.94%-54.4M
-36.75%-50.84M
-45.37%-49.53M
-12.36%-152.63M
-29.21%-42.79M
-8.73%-38.6M
-6.92%-37.17M
-4.98%-34.07M
Depreciation and amortization
-0.12%848K
-4.67%204K
-3.70%208K
-5.16%202K
13.59%234K
11.86%849K
3.88%214K
11.92%216K
16.39%213K
16.38%206K
Other non cash items
9.64%523K
17.65%140K
9.84%134K
4.96%127K
6.09%122K
553.42%477K
--119K
--122K
--121K
--115K
Change In working capital
3,559.97%286.17M
7,505.98%282.26M
13.86%5.74M
-51.20%3.1M
32.41%-4.92M
362.21%7.82M
2,309.74%3.71M
-33.51%5.04M
307.59%6.35M
4.96%-7.28M
-Change in prepaid assets
-354.59%-8.91M
-276.56%-9.54M
-55.38%357K
30.86%2.46M
-3.79%-2.19M
33.22%-1.96M
-287.43%-2.53M
-12.28%800K
173.30%1.88M
19.81%-2.11M
-Change in payables and accrued expense
47.19%15.2M
66.13%12.7M
44.35%5.68M
-101.22%-50K
41.69%-3.13M
1,387.66%10.33M
590.13%7.65M
-38.08%3.93M
1,306.16%4.11M
-2.15%-5.36M
-Change in other current assets
238.25%947K
146.82%685K
-284.06%-508K
70.03%539K
24.86%231K
-219.96%-685K
-524.06%-1.46M
19.48%276K
388.18%317K
76.19%185K
-Change in other current liabilities
453.28%758K
279.03%235K
624.14%210K
336.36%144K
1,200.00%169K
-25.54%137K
264.71%62K
-65.06%29K
189.19%33K
-89.26%13K
-Change in other working capital
--278.18M
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
207.61%134.32M
884.46%269.13M
-49.65%-43.44M
-66.02%-42.53M
-36.16%-48.84M
-13.41%-124.82M
-29.32%-34.31M
-38.16%-29.03M
15.57%-25.62M
-11.47%-35.87M
Investing cash flow
Cash flow from continuing investing activities
-753.02%-101.59M
-325.04%-94.96M
432.01%45.54M
193.18%43.17M
-956.65%-95.34M
-52.32%15.56M
189.17%42.2M
-88.08%8.56M
-239.97%-46.33M
144.58%11.13M
Net PPE purchase and sale
-180.95%-472K
-2,225.00%-372K
--0
83.33%-16K
-133.33%-84K
73.16%-168K
-33.33%-16K
94.75%-20K
47.83%-96K
26.53%-36K
Net investment purchase and sale
-743.04%-101.12M
-324.07%-94.58M
430.77%45.54M
193.41%43.18M
-953.14%-95.25M
-52.71%15.73M
189.23%42.21M
-88.12%8.58M
-238.91%-46.23M
144.82%11.17M
Cash from discontinued investing activities
Investing cash flow
-753.02%-101.59M
-325.04%-94.96M
432.01%45.54M
193.18%43.17M
-956.65%-95.34M
-52.32%15.56M
189.17%42.2M
-88.08%8.56M
-239.97%-46.33M
144.58%11.13M
Financing cash flow
Cash flow from continuing financing activities
62.92%154.42M
16.64%806K
2,521.43%2.2M
-96.77%3.04M
148.37M
145.77%94.78M
-98.01%691K
-90.45%84K
3,422.22%94.01M
0
Net issuance payments of debt
--0
----
----
----
----
--0
----
----
----
----
Net common stock issuance
55.82%145.81M
---1K
--0
--0
--145.81M
278.53%93.58M
--0
--0
--93.58M
--0
Proceeds from stock option exercised by employees
613.43%8.6M
16.79%807K
2,521.43%2.2M
605.34%3.04M
--2.56M
-72.71%1.21M
21.87%691K
-90.45%84K
-83.85%431K
--0
Cash from discontinued financing activities
Financing cash flow
62.92%154.42M
16.64%806K
2,521.43%2.2M
-96.77%3.04M
--148.37M
145.77%94.78M
-98.01%691K
-90.45%84K
3,422.22%94.01M
--0
Net cash flow
Beginning cash position
-27.96%37.32M
72.16%49.48M
-8.02%45.18M
53.39%41.51M
-27.96%37.32M
-42.87%51.8M
-68.40%28.74M
24.47%49.12M
-20.51%27.06M
-43.00%51.8M
Current changes in cash
1,392.07%187.14M
1,939.89%174.98M
121.08%4.3M
-83.34%3.68M
116.93%4.19M
62.74%-14.48M
121.92%8.58M
-139.44%-20.38M
306.73%22.07M
56.47%-24.74M
End cash Position
501.48%224.46M
501.48%224.46M
72.16%49.48M
-8.02%45.18M
53.39%41.51M
-27.96%37.32M
-27.96%37.32M
-68.40%28.74M
24.47%49.12M
-20.51%27.06M
Free cash flow
207.08%133.85M
883.01%268.76M
-49.55%-43.44M
-65.46%-42.55M
-36.26%-48.93M
-12.92%-124.99M
-29.32%-34.32M
-35.79%-29.05M
15.76%-25.71M
-11.41%-35.91M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 207.61%134.32M884.46%269.13M-49.65%-43.44M-66.02%-42.53M-36.16%-48.84M-13.41%-124.82M-29.32%-34.31M-38.16%-29.03M15.57%-25.62M-11.47%-35.87M
Net income from continuing operations -13.99%-173.98M55.09%-19.22M-40.94%-54.4M-36.75%-50.84M-45.37%-49.53M-12.36%-152.63M-29.21%-42.79M-8.73%-38.6M-6.92%-37.17M-4.98%-34.07M
Depreciation and amortization -0.12%848K-4.67%204K-3.70%208K-5.16%202K13.59%234K11.86%849K3.88%214K11.92%216K16.39%213K16.38%206K
Other non cash items 9.64%523K17.65%140K9.84%134K4.96%127K6.09%122K553.42%477K--119K--122K--121K--115K
Change In working capital 3,559.97%286.17M7,505.98%282.26M13.86%5.74M-51.20%3.1M32.41%-4.92M362.21%7.82M2,309.74%3.71M-33.51%5.04M307.59%6.35M4.96%-7.28M
-Change in prepaid assets -354.59%-8.91M-276.56%-9.54M-55.38%357K30.86%2.46M-3.79%-2.19M33.22%-1.96M-287.43%-2.53M-12.28%800K173.30%1.88M19.81%-2.11M
-Change in payables and accrued expense 47.19%15.2M66.13%12.7M44.35%5.68M-101.22%-50K41.69%-3.13M1,387.66%10.33M590.13%7.65M-38.08%3.93M1,306.16%4.11M-2.15%-5.36M
-Change in other current assets 238.25%947K146.82%685K-284.06%-508K70.03%539K24.86%231K-219.96%-685K-524.06%-1.46M19.48%276K388.18%317K76.19%185K
-Change in other current liabilities 453.28%758K279.03%235K624.14%210K336.36%144K1,200.00%169K-25.54%137K264.71%62K-65.06%29K189.19%33K-89.26%13K
-Change in other working capital --278.18M------------------------------------
Cash from discontinued investing activities
Operating cash flow 207.61%134.32M884.46%269.13M-49.65%-43.44M-66.02%-42.53M-36.16%-48.84M-13.41%-124.82M-29.32%-34.31M-38.16%-29.03M15.57%-25.62M-11.47%-35.87M
Investing cash flow
Cash flow from continuing investing activities -753.02%-101.59M-325.04%-94.96M432.01%45.54M193.18%43.17M-956.65%-95.34M-52.32%15.56M189.17%42.2M-88.08%8.56M-239.97%-46.33M144.58%11.13M
Net PPE purchase and sale -180.95%-472K-2,225.00%-372K--083.33%-16K-133.33%-84K73.16%-168K-33.33%-16K94.75%-20K47.83%-96K26.53%-36K
Net investment purchase and sale -743.04%-101.12M-324.07%-94.58M430.77%45.54M193.41%43.18M-953.14%-95.25M-52.71%15.73M189.23%42.21M-88.12%8.58M-238.91%-46.23M144.82%11.17M
Cash from discontinued investing activities
Investing cash flow -753.02%-101.59M-325.04%-94.96M432.01%45.54M193.18%43.17M-956.65%-95.34M-52.32%15.56M189.17%42.2M-88.08%8.56M-239.97%-46.33M144.58%11.13M
Financing cash flow
Cash flow from continuing financing activities 62.92%154.42M16.64%806K2,521.43%2.2M-96.77%3.04M148.37M145.77%94.78M-98.01%691K-90.45%84K3,422.22%94.01M0
Net issuance payments of debt --0------------------0----------------
Net common stock issuance 55.82%145.81M---1K--0--0--145.81M278.53%93.58M--0--0--93.58M--0
Proceeds from stock option exercised by employees 613.43%8.6M16.79%807K2,521.43%2.2M605.34%3.04M--2.56M-72.71%1.21M21.87%691K-90.45%84K-83.85%431K--0
Cash from discontinued financing activities
Financing cash flow 62.92%154.42M16.64%806K2,521.43%2.2M-96.77%3.04M--148.37M145.77%94.78M-98.01%691K-90.45%84K3,422.22%94.01M--0
Net cash flow
Beginning cash position -27.96%37.32M72.16%49.48M-8.02%45.18M53.39%41.51M-27.96%37.32M-42.87%51.8M-68.40%28.74M24.47%49.12M-20.51%27.06M-43.00%51.8M
Current changes in cash 1,392.07%187.14M1,939.89%174.98M121.08%4.3M-83.34%3.68M116.93%4.19M62.74%-14.48M121.92%8.58M-139.44%-20.38M306.73%22.07M56.47%-24.74M
End cash Position 501.48%224.46M501.48%224.46M72.16%49.48M-8.02%45.18M53.39%41.51M-27.96%37.32M-27.96%37.32M-68.40%28.74M24.47%49.12M-20.51%27.06M
Free cash flow 207.08%133.85M883.01%268.76M-49.55%-43.44M-65.46%-42.55M-36.26%-48.93M-12.92%-124.99M-29.32%-34.32M-35.79%-29.05M15.76%-25.71M-11.41%-35.91M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+5.27%
Apple
AAPL
+1.95%
Meta Platforms
META
+1.75%
Microsoft
MSFT
+1.14%
Petroleo Brasileiro SA Petrobras
PBR
+0.93%

Unlock the Full List